Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 152 | 337 | 653 | 0 | 11,158 |
| Gross Profit | 152 | 337 | 653 | N/A | 11,158 |
| Operating Expenses | 27,329 | 22,089 | 14,334 | 18,703 | 15,700 |
| Operating Income | -27,177 | -21,752 | -13,680 | -18,703 | -4,542 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 1,078 | 648 | 980 | 1,775 | -444 |
| Pre-tax Income | -26,099 | -21,104 | -12,700 | -16,929 | -4,986 |
| Net Income Continuous | -26,099 | -21,104 | -12,700 | -16,929 | -4,986 |
| Net Income | $-26,099 | $-21,104 | $-12,700 | $-16,929 | $-4,986 |
| EPS Basic Total Ops | -1.01 | -1.00 | -0.72 | -0.96 | -0.28 |
| EPS Basic Continuous Ops | -1.01 | -1.00 | -0.72 | -0.96 | -0.28 |
| EPS Diluted Total Ops | -1.01 | -1.00 | -0.72 | -0.96 | -0.28 |
| EPS Diluted Continuous Ops | -1.01 | -1.00 | -0.72 | -0.96 | -0.28 |
| EBITDA(a) | $-26,159 | $-20,793 | $-12,579 | $-17,457 | $-3,492 |